Anlon Healthcare Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- ✓Strong return on equity (ROE 18.4%)
- ✓Efficient capital deployment (ROCE 20.8%)
- ✓Attractively valued vs sector (P/E 27.5x vs industry 54.4x)
- ✓Trading below book value (P/B 0.3x)
- ✓Low debt relative to equity (D/E 0.2x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Latest News
All news →Anlon Healthcare announces board meeting outcomes.
*Anlon Healthcare announces board meeting outcomes.* The company disclosed outcomes from its recent board meeting held on July 01, 2026. Details include routine corporate matters with no major financial implications. Specifics were not highlighted in the filing. 📊 *STOCKS:* ANLONHEALTH | 🏢 *SECTOR:* Pharma | #LOWIMPACT #BoardMeeting
Anlon Healthcare acquires 63.98% stake in Remember India Health Links
*Anlon Healthcare acquires 63.98% stake in Remember India Health Links*\nAnlon Healthcare has completed the acquisition of a **63.98% equity stake** in Remember India Health Links Private Limited, marking a strategic expansion in the healthcare sector. The move strengthens Anlon’s footprint in health services and distribution. This acquisition is expected to enhance revenue streams and operational synergy.\n\n📊 *STOCKS:* ANLONHEALTH | 🏢 *SECTOR:* Corporate | #HIGHIMPACT #Acquisition
Anlon Healthcare Chairman to appear on Money TV
Anlon Healthcare's Chairman & Managing Director will be featured in an interview on Money TV. The segment may provide insights into the company’s strategy and operations. *Anlon Healthcare Chairman to appear on Money TV*. While not a material business update, it could influence retail sentiment. 📊 *STOCKS:* ANLONHEALTH | 🏢 *SECTOR:* Pharma | #LOWIMPACT #mediaappearance
Anlon Healthcare to appear on NDTV Profit for interview
*Anlon Healthcare to appear on NDTV Profit for interview.* The company has issued a disclosure under SEBI's Regulation 30 regarding an upcoming TV interview. Such media appearances may lead to increased stock visibility but carry no material business update. Investors should watch for any strategic announcements during the segment. 📊 *STOCKS:* ANLONHEALTH | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Regulation30
Anlon Healthcare hosts analyst and investor call
*Anlon Healthcare hosts analyst and investor call* to discuss business updates. The company provided insights during the investor meet with no major announcements. Transcript available via NSE corporate filing. 📊 *STOCKS:* ANLON | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorCall
Anlon Healthcare acquires Remember India in undisclosed deal
Anlon Healthcare has acquired Remember India, a move advised by Vidhigya Associates. The financial terms of the deal, including the acquisition value, were not disclosed. Such small-scale acquisitions typically have limited market impact unless strategic significance emerges later. 📊 *STOCKS:* | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #Acquisition
About Anlon Healthcare Limited
Incorporated in 2013, Anlon Healthcare Limited is a chemical manufacturing company engaged in the manufacturing of Pharma Intermediates and active pharmaceutical ingredients (APIs).[1]
Healthcare · Pharmaceuticals & Biotechnology